- Home
- WLGS vs ADTX Comparison
WLGS vs ADTX Comparison
Compare WLGS & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- ADTX
- Stock Information
- Founded
- WLGS 1981
- ADTX 2017
- Country
- WLGS Hong Kong
- ADTX United States
- Employees
- WLGS N/A
- ADTX N/A
- Industry
- WLGS Engineering & Construction
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- ADTX Health Care
- Exchange
- WLGS Nasdaq
- ADTX Nasdaq
- Market Cap
- WLGS 4.7M
- ADTX 5.3M
- IPO Year
- WLGS 2023
- ADTX 2020
- Fundamental
- Price
- WLGS $0.21
- ADTX $2.30
- Analyst Decision
- WLGS
- ADTX
- Analyst Count
- WLGS 0
- ADTX 0
- Target Price
- WLGS N/A
- ADTX N/A
- AVG Volume (30 Days)
- WLGS 3.3M
- ADTX 595.9K
- Earning Date
- WLGS 05-06-2025
- ADTX 05-19-2025
- Dividend Yield
- WLGS N/A
- ADTX N/A
- EPS Growth
- WLGS N/A
- ADTX N/A
- EPS
- WLGS 0.02
- ADTX N/A
- Revenue
- WLGS $7,272,879.00
- ADTX $133,985.00
- Revenue This Year
- WLGS N/A
- ADTX $15,768.94
- Revenue Next Year
- WLGS N/A
- ADTX N/A
- P/E Ratio
- WLGS $10.64
- ADTX N/A
- Revenue Growth
- WLGS 66.93
- ADTX N/A
- 52 Week Low
- WLGS $0.20
- ADTX $2.04
- 52 Week High
- WLGS $9.66
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- WLGS 28.21
- ADTX 30.49
- Support Level
- WLGS $0.16
- ADTX $2.04
- Resistance Level
- WLGS $0.20
- ADTX $2.39
- Average True Range (ATR)
- WLGS 0.03
- ADTX 0.45
- MACD
- WLGS 0.18
- ADTX 0.48
- Stochastic Oscillator
- WLGS 38.11
- ADTX 7.54
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.